Edition:
United Kingdom

People: Shin Nippon Biomedical Laboratories Ltd (2395.T)

2395.T on Tokyo Stock Exchange

701JPY
24 Jun 2019
Change (% chg)

¥2 (+0.29%)
Prev Close
¥699
Open
¥703
Day's High
¥709
Day's Low
¥683
Volume
343,800
Avg. Vol
627,826
52-wk High
¥980
52-wk Low
¥442

Yamakawa, Takeshi 

Mr. Takeshi Yamakawa has been serving as Director in SHIN NIPPON BIOMEDICAL LABORATORIES, LTD, as well as Chief Executive Officer in a subsidiary SNBL Clinical Pharmacy Center,Inc., since June 2011. He is also Vice Chairman of another subsidiary, SNBL U.S.A.,Ltd. He joined the Company in October 2010. His previous titles include Executive Officer and Managing Executive Officer. Mr. Yamakawa used to work for Ministry of Internal Affairs and Communications, as well as Ministry of Foreign Affairs of Japan.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --